|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/165 | (2006.01) |
| A61P 25/00 | (2006.01) | ||
| A61P 25/24 | (2006.01) | ||
| A61P 25/22 | (2006.01) | ||
| A61P 25/18 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 2222290 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08864461.2 |
| Date of filing the European patent application | 2008-12-05 | |
| (97) | Date of publication of the European application | 2010-09-01 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2008/066884 |
| Date | 2008-12-05 |
| (87) | Number | WO 2009/080470 |
| Date | 2009-07-02 |
| (30) | Number | Date | Country code |
| 07024584 | 2007-12-19 | EP |
| (72) |
IZZO, Emanuela , IT
FARAVELLI, Laura , IT
BARBANTI, Elena , IT
SALVATI, Patricia , IT
|
| (73) |
Newron Pharmaceuticals S.p.A. ,
Via Antonio Meucci, 3, 20091 Bresso (MI),
IT
|
| (54) | ALPHA-AMINOAMIDE DERIVATIVES FOR THE TREATMENT OF PSYCHIATRIC DISORDERS |
| ALPHA-AMINOAMIDE DERIVATIVES FOR THE TREATMENT OF PSYCHIATRIC DISORDERS |